Nuvo Research (Dimethaid Research) signs license agreement with Ranbaxy Laboratories

Posted on: Thu, 12 Nov 2009 14:07:00 EST


Symbols: RBXLF, NRIFF
Nov 12, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
RBXLF | Quote | Chart | News | PowerRating -- Dimethaid GmbH, a Germany-based subsidiary of Nuvo Research, Inc., has entered into an exclusive license agreement with Ranbaxy Laboratories Limited, for the supply and distribution of Oxoferin(TM) in Malaysia, Cambodia, Philippines, Vietnam, Myanmar, and Singapore.

Both the India-based Ranbaxy and Canada-based Nuvo Research are engaged in pharmaceutical business.

Under the terms of the agreement, Nuvo Research will manufacture and supply Oxoferin(TM) to Ranbaxy. Ranbaxy will be responsible for obtaining regulatory approval in Malaysia, Cambodia, Philippines, Vietnam, Myanmar, and Singapore, and has committed to minimum annual purchase quantities once approved.

Deal Type    Partnership
Sub-Category Acquisition of Rights,Distribution,Supply
Deal Status Announced: 2009-11-11

Deal Participants

Partner 1 (Company) Ranbaxy Laboratories Limited
Partner 2 (Company) Nuvo Research, Inc. (formerly Dimethaid Research, Inc.)
Partner 3 (Company) Dimethaid GmbH

For full details on (RBXLF) RBXLF. (RBXLF) has Short Term PowerRatings at TradingMarkets. Details on (RBXLF) Short Term PowerRatings is available at This Link.

For full details on (NRIFF) NRIFF. (NRIFF) has Short Term PowerRatings at TradingMarkets. Details on (NRIFF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.